{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:42:14Z","timestamp":1761100934214,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bcmd.2007.07.004","type":"journal-article","created":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T07:31:13Z","timestamp":1191310273000},"page":"8-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["The haploidentical option for high-risk haematological malignancies"],"prefix":"10.1016","volume":"40","author":[{"given":"Franco","family":"Aversa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Reisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo F.","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2007.07.004_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.07.004_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1471-4906(02)02284-6","article-title":"NK cells: a lesson from mismatched hematopoietic transplantation","volume":"23","author":"Velardi","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bcmd.2007.07.004_bib3","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2007.07.004_bib4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/nm1295-1268","article-title":"Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice","volume":"1","author":"Bachar-Lustig","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2007.07.004_bib5","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell-depleted haploidentical \u201cthree-loci\u201d incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.07.004_bib6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2007.07.004_bib7","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full-haplotype mismatched hematopoietic stem cell transplantation: a phase II study in patients with acute leukemia at high risk or relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2007.07.004_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bmt.1703362","article-title":"Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique","volume":"29","author":"Meijer","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2007.07.004_bib9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1399-0012.2004.00198.x","article-title":"Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein\u2013Barr virus load in the peripheral blood of bone marrow transplant recipients","volume":"18","author":"Liu","year":"2004","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.bcmd.2007.07.004_bib10","first-page":"3101","article-title":"Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: Preliminary results","volume":"28","author":"Terenzi","year":"1996","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.bcmd.2007.07.004_bib11","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood.V97.8.2514","article-title":"Post-grafting granulocyte colony-stimulating factor administration impairs functional immune recovery in recipients of HLA haplotype-mismatched hematopoietic transplants","volume":"97","author":"Volpi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2007.07.004_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbmt.2006.10.017","article-title":"Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis","volume":"13","author":"Russell","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2007.07.004_bib13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1083-8791(03)00127-7","article-title":"Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation","volume":"9","author":"Waller","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2007.07.004_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcmd.2007.07.004_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/CCO.0b013e3280148a1a","article-title":"Natural killer cell alloreactivity in allogeneic hematopoietic transplantation","volume":"19","author":"Ruggeri","year":"2007","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.bcmd.2007.07.004_bib16","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979607001313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979607001313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:25:33Z","timestamp":1761049533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979607001313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1079979607001313"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2007.07.004","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The haploidentical option for high-risk haematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2007.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}